The Neurofibromatosis Institute

The Neurofibromatosis Institute was a specialized U.S. neurofibromatosis-focused clinical and research organization founded by Vincent M. Riccardi in 1980. It appears to have operated primarily as a patient care and disease-focused institute rather than as a traditional drug-development biotech company, with work centered on diagnosis, treatment support, and advancing understanding of neurofibromatosis. Public business-registry records indicate the California entity The Neurofibromatosis Institute, Inc. was dissolved in 2008. Available evidence does not show an active therapeutic pipeline, proprietary drug platform, or biopharma partnering model typical of venture-backed biotech companies.